Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cel-Sci Corp (AMEX:CVM) (was HIV) -- Ignore unavailable to you. Want to Upgrade?

To: Alan Brezin who wrote (2621)	8/23/1999 8:46:00 AM
From: Tom Shutters	Respond to of 2836

"Mystery Bidder Gives Cel-Sci a Ride" "Monday, August 23, 1999; Page F25" "Shares of Cel-Sci Corp., the little Vienna biotech company with the stock symbol HIV, jumped 81 percent last week, and under head-spinning circumstances." "On Wednesday, the Public Relations Newswire had an announcement from a lawyer in Argentina who said his client, a company in the British West Indies, was making an unsolicited buyout offer for Cel-Sci of $124 million, or $7.75 a share." "The stock quickly jumped to $3 a share from less than $2 a share, only to slip back Thursday after Cel-Sci said it hadn't been able to contact the lawyer and couldn't tell whether the offer was genuine." "On Friday there was another press release from the lawyer insisting that his client, identified only as Cel-Sci Acquisition Corp., was indeed interested in a friendly takeover. The stock rose again, to $3.50 a share, but there still was no answer to the question of who was making the offer and if it is, in fact, legitimate."... washingtonpost.com